Cargando…
Effectiveness of Montelukast on asthma control in infants: methodology of a French claims data study
BACKGROUND: This pilot study, conducted on a 1/97th representative sample of French claims data, prepared a project to assess the effectiveness of Montelukast (MTL-4) as add-on therapy for asthma in infants (6–24 months) compared to inhaled corticosteroids (ICS), based on real-world data. Due to the...
Autores principales: | Belhassen, Manon, de Pouvourville, Gérard, Laforest, Laurent, Brouard, Jacques, de Blic, Jacques, Fauroux, Brigitte, Laigle, Valérie, Chanut-Vogel, Céline, Lamezec, Liliane, Van Ganse, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450509/ https://www.ncbi.nlm.nih.gov/pubmed/25934554 http://dx.doi.org/10.1186/s12890-015-0047-6 |
Ejemplares similares
-
Recurrent Wheezing in Infants: A Population-Based Study
por: Belhassen, Manon, et al.
Publicado: (2016) -
Prescribed therapy for asthma: therapeutic ratios and outcomes
por: Laforest, Laurent, et al.
Publicado: (2015) -
Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study
por: Dalon, Faustine, et al.
Publicado: (2019) -
Dans l’asthme intermittent de l’enfant entre 2 et 5 ans, le montelukast réduit la fréquence des exacerbations (étude PREVIA)
por: de Blic, J.
Publicado: (2005) -
Erratum to: Prescribed therapy for asthma: therapeutic ratios and outcomes
por: Laforest, Laurent, et al.
Publicado: (2016)